Dr Roy D Flood Jr, MD | |
1326 Eisenhower Dr, Bldg 2, Savannah, GA 31406-3928 | |
(912) 527-5300 | |
(912) 524-5154 |
Full Name | Dr Roy D Flood Jr |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 34 Years |
Location | 1326 Eisenhower Dr, Savannah, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336124338 | NPI | - | NPPES |
003179450E | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 076076 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph's Hospital - Savannah | Savannah, GA | Hospital |
Candler Hospital | Savannah, GA | Hospital |
Nash General Hospital | Rocky mount, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sj Sc Cardiology Llc | 1052607371 | 8 |
Nhcs Physicians Inc | 7719209154 | 63 |
News Archive
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way.
Brown University researchers have discovered that Candida albicans, a human fungal pathogen that causes thrush and other diseases, pursues same-sex mating in addition to conventional opposite-sex mating.
› Verified 1 days ago
Entity Name | Southcoast Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467451922 PECOS PAC ID: 9032013271 Enrollment ID: O20040109000192 |
News Archive
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way.
Brown University researchers have discovered that Candida albicans, a human fungal pathogen that causes thrush and other diseases, pursues same-sex mating in addition to conventional opposite-sex mating.
› Verified 1 days ago
Entity Name | Sj Sc Cardiology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245694496 PECOS PAC ID: 1052607371 Enrollment ID: O20160912002197 |
News Archive
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way.
Brown University researchers have discovered that Candida albicans, a human fungal pathogen that causes thrush and other diseases, pursues same-sex mating in addition to conventional opposite-sex mating.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Roy D Flood Jr, MD Po Box 15849, Savannah, GA 31416-2549 Ph: (912) 303-3560 | Dr Roy D Flood Jr, MD 1326 Eisenhower Dr, Bldg 2, Savannah, GA 31406-3928 Ph: (912) 527-5300 |
News Archive
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way.
Brown University researchers have discovered that Candida albicans, a human fungal pathogen that causes thrush and other diseases, pursues same-sex mating in addition to conventional opposite-sex mating.
› Verified 1 days ago
Florin C Georgescu, M. D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 E 66th St, Savannah, GA 31405 Phone: 912-356-5643 Fax: 912-356-9712 | |
James A Daly Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 340 Hodgson Ct, Suite 2, Savannah, GA 31406 Phone: 912-629-2290 Fax: 912-629-2291 | |
Elizabeth Florence Cornell, DO Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 6602 Waters Ave Bldg A, Savannah, GA 31406 Phone: 912-350-6000 Fax: 912-350-6001 | |
Dr. Kinhtu Lien, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-7573 | |
Dr. Barry James Krakow, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 211 Early St, Savannah, GA 31405 Phone: 505-238-7519 | |
Dr. John David Northup, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12345 Mercy Blvd, Savannah, GA 31419 Phone: 912-927-3046 Fax: 912-925-0597 | |
Samuel David Patrick Mcelroy, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4451 Paulsen St, Savannah, Savannah, GA 31405 Phone: 912-350-7500 Fax: 912-350-7735 |